ABCA12 regulates insulin secretion from β-cells.
Gloria M UrsinoYing FuDenny L CottleNigora MukhamedovaLynelle K JonesHann LowMing Shen ThamWan Jun GanNatalie A MellettPartha P DasJacquelyn M WeirMichael DitiatkovskiStacey FynchPeter ThornHelen E ThomasPeter J MeikleHelena C ParkingtonIan M SmythDmitri SviridovPublished in: EMBO reports (2020)
Dysregulation of lipid homeostasis is intimately associated with defects in insulin secretion, a key feature of type 2 diabetes. Here, we explore the role of the putative lipid transporter ABCA12 in regulating insulin secretion from β-cells. Mice with β-cell-specific deletion of Abca12 display impaired glucose-stimulated insulin secretion and eventual islet inflammation and β-cell death. ABCA12's action in the pancreas is independent of changes in the abundance of two other cholesterol transporters, ABCA1 and ABCG1, or of changes in cellular cholesterol or ceramide content. Instead, loss of ABCA12 results in defects in the genesis and fusion of insulin secretory granules and increases in the abundance of lipid rafts at the cell membrane. These changes are associated with dysregulation of the small GTPase CDC42 and with decreased actin polymerisation. Our findings establish a new, pleiotropic role for ABCA12 in regulating pancreatic lipid homeostasis and insulin secretion.
Keyphrases
- cell death
- cell cycle arrest
- induced apoptosis
- fatty acid
- oxidative stress
- type diabetes
- machine learning
- blood pressure
- adipose tissue
- endoplasmic reticulum stress
- low density lipoprotein
- blood glucose
- signaling pathway
- metabolic syndrome
- skeletal muscle
- deep learning
- antibiotic resistance genes
- high fat diet induced
- weight loss
- neural network